Page last updated: 2024-08-26

benzyl selenocyanate and Benign Neoplasms

benzyl selenocyanate has been researched along with Benign Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baquedano, Y; Font, M; Jiménez-Ruiz, A; Moreno-Mateos, D; Palop, JA; Plano, D; Sanmartín, C	1
Guengerich, FP; Komori, M; Murayama, N; Shimada, T; Takenaka, S; Tanaka, K; Yamazaki, H	1

Other Studies

2 other study(ies) available for benzyl selenocyanate and Benign Neoplasms

Article	Year
Selenocyanates and diselenides: a new class of potent antileishmanial agents. European journal of medicinal chemistry, 2011, Volume: 46, Issue:8 Topics: Aminophenols; Animals; Antiprotozoal Agents; Cell Line, Tumor; Cyanates; Humans; Inhibitory Concentration 50; Leishmania infantum; Leishmaniasis, Visceral; Life Cycle Stages; Monocytes; Neoplasms; Phospholipid Ethers; Phosphorylcholine; Selenium Compounds; Structure-Activity Relationship	2011
Spectral modification and catalytic inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2A6, and 2A13 by four chemopreventive organoselenium compounds. Chemical research in toxicology, 2011, Aug-15, Volume: 24, Issue:8 Topics: Animals; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Binding Sites; Biocatalysis; Catalytic Domain; Computer Simulation; Cyanates; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1B1; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Humans; Neoplasms; Organoselenium Compounds; Protein Binding; Rats	2011

Article

Year

Selenocyanates and diselenides: a new class of potent antileishmanial agents.

European journal of medicinal chemistry, 2011, Volume: 46, Issue:8

Topics: Aminophenols; Animals; Antiprotozoal Agents; Cell Line, Tumor; Cyanates; Humans; Inhibitory Concentration 50; Leishmania infantum; Leishmaniasis, Visceral; Life Cycle Stages; Monocytes; Neoplasms; Phospholipid Ethers; Phosphorylcholine; Selenium Compounds; Structure-Activity Relationship

2011

Spectral modification and catalytic inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2A6, and 2A13 by four chemopreventive organoselenium compounds.

Chemical research in toxicology, 2011, Aug-15, Volume: 24, Issue:8

Topics: Animals; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Binding Sites; Biocatalysis; Catalytic Domain; Computer Simulation; Cyanates; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1B1; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Humans; Neoplasms; Organoselenium Compounds; Protein Binding; Rats

2011